New Fund for medicine
Inconsistent and confused generalisations about the relationship between the UK pharmaceutical industry and the NHS have persisted for years.
Cyber-security threat
The cyber-breach of the UK NHS earlier in 2017, which froze computers in hospitals across the country, highlighted the growing problem of cyber-attacks and corporate espionage. Jesse Klebba, CEO of Urgent Technology comments.
Catalytic future
New product route definition and commercialisation remain a largely subjective exercise in the pharmaceutical sector.
Robots gear up
Graham Mackrell, Managing Director at Harmonic Drive UK, on the increasing market effect of robotics.
Deep learning for agrchems
Robotics is quietly transforming many aspects of agriculture, including the agrochemicals sector.
Simplifying impurity analysis
Standard methods for the determination and control of heavy metal contamination in pharmaceutical products and dietary supplements have hardly altered over the past century.
Downtime is money
Few things can damage the financial stability of a manufacturing facility more than unexpected downtime. Lee Sullivan from COPA-DATA UK comments.
Low fat CSR
Companies that have gone the extra mile in ensuring their wastewater has a minimal environmental impact will have the competitive edge. Steven Martin from Wastewater and Biological Innovation Platform comments.
Encouraging future scientists
The Children Challenging Industry (CCI) programme, pioneered by former SCI president Tom Swan, has been running in the North of England since 1996. Nick Cooke, Managing Director at Sartorius, explains its importance to budding scientists.
Cyclical client demand for CMOs
Trends in most industries tend to be cyclical and the pharmaceutical contract manufacturing industry is no exception. Looking back at contract manufacturing organisations (CMOs) over the last forty years, a number of defined stages and trends have become apparent in their evolution.